Patients who have a history of heart disease but have stabilised now, benefit substantially when treated, with Ticagrelor. Often this is combined, with aspirin for additional advantages. The risk of episodes of newer ischemic attacks is greatly reduced using this therapy. However, the negative side is that the chances of bleeding increase over a period of time after regular consumption of this drug.
After about a year after being treated, with dual anti platelet ticagrelor, the chances of a stroke or death from cardio vascular disease is substantially reduced as compared to being treated, with aspirin alone as was formerly the case. Medical research has shown that the best dose that is best tol...
Also read: The brain can produce its own sugar: Report